# KRN125 for Mobilization of Hematopoietic Stem Cells

> **NCT03993639** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 35 (actual)

## Conditions studied

- Peripheral Blood Stem Cell Transplantation

## Interventions

- **DRUG:** Pegfilgrastim

## Key facts

- **NCT ID:** NCT03993639
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-28
- **Primary completion:** 2020-07-21
- **Final completion:** 2020-08-28
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03993639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03993639, "KRN125 for Mobilization of Hematopoietic Stem Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03993639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*